These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31337618)

  • 1. Distinct Colorectal Cancer-Associated APC Mutations Dictate Response to Tankyrase Inhibition.
    Schatoff EM; Goswami S; Zafra MP; Foronda M; Shusterman M; Leach BI; Katti A; Diaz BJ; Dow LE
    Cancer Discov; 2019 Oct; 9(10):1358-1371. PubMed ID: 31337618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer.
    Yakkala PA; Naaz F; Shafi S; Kamal A
    Expert Opin Ther Targets; 2024 Mar; 28(3):159-177. PubMed ID: 38497299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Apc
    Guo B; Zheng Y; Fan Y; Yang Y; Wang Y; Qin L; An Y; Xu X; Zhang X; Sun G; Dou H; Shao C; Gong Y; Jiang B; Hu H
    Neoplasia; 2024 Jul; 53():101005. PubMed ID: 38761506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.
    Szvicsek Z; Oszvald Á; Szabó L; Sándor GO; Kelemen A; Soós AÁ; Pálóczi K; Harsányi L; Tölgyes T; Dede K; Bursics A; Buzás EI; Zeöld A; Wiener Z
    Cell Mol Life Sci; 2019 Jun; 76(12):2463-2476. PubMed ID: 31028424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profiling of mouse intestinal organoids for studying APC mutations.
    Jukes Z; Freier A; Glymenaki M; Brown R; Parry L; Want E; Vorkas PA; Li JV
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33620068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells.
    Schmidt O; Brückner M; Bernkopf DB
    FEBS J; 2024 Jul; ():. PubMed ID: 39022865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase.
    Xu W; Lau YH; Fischer G; Tan YS; Chattopadhyay A; de la Roche M; Hyvönen M; Verma C; Spring DR; Itzhaki LS
    J Am Chem Soc; 2017 Feb; 139(6):2245-2256. PubMed ID: 28084734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis.
    Fletcher R; Tong J; Risnik D; Leibowitz BJ; Wang YJ; Concha-Benavente F; DeLiberty JM; Stolz DB; Pai RK; Ferris RL; Schoen RE; Yu J; Zhang L
    Oncogene; 2021 Mar; 40(11):2035-2050. PubMed ID: 33603166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention.
    Kelson CO; Zaytseva YY
    Front Oncol; 2024; 14():1343061. PubMed ID: 38590663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TNKS/USP25 inhibitor blocks the Wnt pathway to overcome multi-drug resistance in TNKS-overexpressing colorectal cancer.
    Zhu H; Gao Y; Liu L; Tao M; Lin X; Cheng Y; Shen Y; Xue H; Guan L; Zhao H; Liu L; Wang S; Yang F; Zhou Y; Liao H; Sun F; Lin H
    Acta Pharm Sin B; 2024 Jan; 14(1):207-222. PubMed ID: 38261825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel targeting approaches and signaling pathways of colorectal cancer: An insight.
    Tiwari A; Saraf S; Verma A; Panda PK; Jain SK
    World J Gastroenterol; 2018 Oct; 24(39):4428-4435. PubMed ID: 30357011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors.
    He X; Huang N; Qiu Y; Zhang J; Liu Y; Yin XL; Lu S
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer.
    Chang CC; Pan SF; Wu MH; Cheng CT; Su YR; Jiang SJ; Hsu HJ
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tankyrase inhibition sensitizes cells to CDK4 blockade.
    Foronda M; Tarumoto Y; Schatoff EM; Leach BI; Diaz BJ; Zimmerman J; Goswami S; Shusterman M; Vakoc CR; Dow LE
    PLoS One; 2019; 14(12):e0226645. PubMed ID: 31891587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An
    Zafra MP; Parsons MJ; Kim J; Alonso-Curbelo D; Goswami S; Schatoff EM; Han T; Katti A; Fernandez MTC; Wilkinson JE; Piskounova E; Dow LE
    Cancer Discov; 2020 Nov; 10(11):1654-1671. PubMed ID: 32792368
    [No Abstract]   [Full Text] [Related]  

  • 16. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
    Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
    Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
    Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
    Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase.
    Jang MK; Mashima T; Seimiya H
    Mol Cancer Ther; 2020 Mar; 19(3):765-776. PubMed ID: 31907221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy.
    Hinze L; Labrosse R; Degar J; Han T; Schatoff EM; Schreek S; Karim S; McGuckin C; Sacher JR; Wagner F; Stanulla M; Yuan C; Sicinska E; Giannakis M; Ng K; Dow LE; Gutierrez A
    Cancer Discov; 2020 Nov; 10(11):1690-1705. PubMed ID: 32703769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tankyrase inhibition augments neuronal insulin sensitivity and glucose uptake via AMPK-AS160 mediated pathway.
    Manglani K; Dey CS
    Neurochem Int; 2020 Dec; 141():104854. PubMed ID: 33002563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.